Therapeutics

Top Story

Ixekizumab, brodalumab show strongest clinical benefit in psoriasis

January 14, 2020
In the Journals

No link found between podophyllotoxin, adverse fetal outcomes

January 10, 2020
No association was found between exposure to podophyllotoxin during pregnancy and adverse fetal outcomes, according to a registry-based cohort study conducted in…
In the Journals

Oral propranolol may be safe in infants with PHACE syndrome

December 20, 2019
Oral propranolol yielded no serious adverse events and few nonserious events in a cohort of infants with PHACE syndrome, according to a study. “Oral propranolol is…

BE SURE study: Bimekizumab achieves PASI 90 at 16 weeks in psoriasis

December 16, 2019
The investigational IL-17A and IL-17F inhibitor bimekizumab was superior to adalimumab in achieving a 90% improvement in Psoriasis Area and Severity Index score after 16…
More Headlines »
Healio Jobs